Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment

Dynamic FDG-PET in Aggressive Lymphoma and Pancreas Cancer

To assess a quantitative kinetic model of FDG uptake measurement using PET in patients with aggressive Non-Hodgkin's lymphoma and cancer of the pancreas, malignancies with known variability in disease aggressiveness and prognosis, for optimized tailoring of the therapeutic strategy in the individual patient.

Inclusion Criteria:

• age>18
• newly diagnosed untreated aggressive NHL
• newly diagnosed untreated cancer of pancreas

Exclusion Criteria:

• none